Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 04/2018, Volume 124, pp. 66 - 72
To undertake a systematic review to determine the diagnostic performance of whole body MRI (WBMRI) including diffusion weighted sequences (DWI) compared to...
Whole-body CT | 18F-FDG PET/CT | Whole-body MRI | Multiple myeloma | DWI | F-FDG PET/CT
Whole-body CT | 18F-FDG PET/CT | Whole-body MRI | Multiple myeloma | DWI | F-FDG PET/CT
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 2014, Volume 111, Issue 3, pp. 330 - 339
Abstract Squamous cell carcinoma of the anus (SCCA) is a rare cancer but its incidence is increasing throughout the world, and is particularly high in the...
Hematology, Oncology and Palliative Medicine | Treatment | Diagnosis | Anal cancer | Guidelines | Follow-up | MITOMYCIN-C | RANDOMIZED-TRIAL | CHEMORADIOTHERAPY | FLUOROURACIL | 5-FLUOROURACIL | ONCOLOGY | NATIONAL COHORT | ACTIVE ANTIRETROVIRAL THERAPY | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prognosis | Follow-Up Studies | Carcinoma, Squamous Cell - virology | Humans | Carcinoma, Squamous Cell - therapy | Anus Neoplasms - virology | Male | Combined Modality Therapy | Lymphatic Metastasis | Anus Neoplasms - diagnosis | Carcinoma, Squamous Cell - diagnosis | Societies, Medical | Anus Neoplasms - therapy | Medical Oncology - standards | Female | Practice guidelines (Medicine) | Squamous cell carcinoma | Mitomycin | Health aspects | Papillomavirus infections | Anus Neoplasms | Carcinoma, Squamous Cell | Life Sciences | Medical Oncology | Santé publique et épidémiologie
Hematology, Oncology and Palliative Medicine | Treatment | Diagnosis | Anal cancer | Guidelines | Follow-up | MITOMYCIN-C | RANDOMIZED-TRIAL | CHEMORADIOTHERAPY | FLUOROURACIL | 5-FLUOROURACIL | ONCOLOGY | NATIONAL COHORT | ACTIVE ANTIRETROVIRAL THERAPY | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prognosis | Follow-Up Studies | Carcinoma, Squamous Cell - virology | Humans | Carcinoma, Squamous Cell - therapy | Anus Neoplasms - virology | Male | Combined Modality Therapy | Lymphatic Metastasis | Anus Neoplasms - diagnosis | Carcinoma, Squamous Cell - diagnosis | Societies, Medical | Anus Neoplasms - therapy | Medical Oncology - standards | Female | Practice guidelines (Medicine) | Squamous cell carcinoma | Mitomycin | Health aspects | Papillomavirus infections | Anus Neoplasms | Carcinoma, Squamous Cell | Life Sciences | Medical Oncology | Santé publique et épidémiologie
Journal Article
Critical reviews in oncology/hematology, ISSN 1040-8428, 04/2018, Volume 124, pp. 66 - 72
To undertake a systematic review to determine the diagnostic performance of whole body MRI (WBMRI) including diffusion weighted sequences (DWI) compared to...
Predictive Value of Tests | Multiple Myeloma - pathology | Multiple Myeloma - diagnosis | Humans | Sensitivity and Specificity | Multimodal Imaging - methods | Magnetic Resonance Imaging - methods | Tomography, X-Ray Computed - methods | Fluorodeoxyglucose F18 | Whole Body Imaging - methods | Positron Emission Tomography Computed Tomography - methods
Predictive Value of Tests | Multiple Myeloma - pathology | Multiple Myeloma - diagnosis | Humans | Sensitivity and Specificity | Multimodal Imaging - methods | Magnetic Resonance Imaging - methods | Tomography, X-Ray Computed - methods | Fluorodeoxyglucose F18 | Whole Body Imaging - methods | Positron Emission Tomography Computed Tomography - methods
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 04/2018, Volume 124, p. 66
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.critrevonc.2018.02.012 To...
Medical research | Medicine, Experimental | Tomography | Diagnostic imaging | Comparative analysis
Medical research | Medicine, Experimental | Tomography | Diagnostic imaging | Comparative analysis
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 11/2018, Volume 102, Issue 4, pp. 1083 - 1089
Radiomics describes the extraction of multiple, otherwise invisible, features from medical images that, with bioinformatic approaches, can be used to provide...
CELL LUNG-CANCER | F-18-FDG PET | MEDICAL IMAGES | ONCOLOGY | RECONSTRUCTION | INTRATUMOR HETEROGENEITY | TUMOR TEXTURE ANALYSIS | CHEMORADIOTHERAPY | ESOPHAGEAL CANCER | THERAPEUTIC RESPONSE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | FEATURES | Medical research | PET imaging | Machine learning | Radiation | Medicine, Experimental | Radiotherapy | Medical imaging equipment | Biomedical engineering | Index Medicus
CELL LUNG-CANCER | F-18-FDG PET | MEDICAL IMAGES | ONCOLOGY | RECONSTRUCTION | INTRATUMOR HETEROGENEITY | TUMOR TEXTURE ANALYSIS | CHEMORADIOTHERAPY | ESOPHAGEAL CANCER | THERAPEUTIC RESPONSE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | FEATURES | Medical research | PET imaging | Machine learning | Radiation | Medicine, Experimental | Radiotherapy | Medical imaging equipment | Biomedical engineering | Index Medicus
Journal Article
Nuclear Medicine Communications, ISSN 0143-3636, 06/2019, Volume 40, Issue 6, pp. 611 - 617
PURPOSETreatment of metastatic colorectal cancer frequently includes antiangiogenic agents such as bevacizumab. Size measurements are inadequate to assess...
18F-FDG PET | colorectal cancer | xenograft | Original | texture analysis | tumor heterogeneity
18F-FDG PET | colorectal cancer | xenograft | Original | texture analysis | tumor heterogeneity
Journal Article
Nuclear Medicine Communications, ISSN 0143-3636, 06/2019, Volume 40, Issue 6, pp. 611 - 617
Journal Article
BRITISH JOURNAL OF RADIOLOGY, ISSN 0007-1285, 2017, Volume 90, Issue 1077, p. 20170347
Since 2010 the portfolio of positron emission tomography (PET)-based imaging has been expanded by industry with the introduction of combined whole-body PET/MRI...
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET/CT | Multimodal Imaging - economics | Positron-Emission Tomography - economics | Humans | Multimodal Imaging - methods | Magnetic Resonance Imaging - economics | Whole Body Imaging - methods | Whole Body Imaging - economics | Diagnostic Radiology | Pet
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET/CT | Multimodal Imaging - economics | Positron-Emission Tomography - economics | Humans | Multimodal Imaging - methods | Magnetic Resonance Imaging - economics | Whole Body Imaging - methods | Whole Body Imaging - economics | Diagnostic Radiology | Pet
Journal Article
Molecular Imaging and Biology, ISSN 1536-1632, 08/2019, Volume 21, Issue 4, p. 781
To establish whether first-order statistical features from [[.sup.18]F]fluoride and 2-deoxy-2[-[.sup.18]F] fluoro-d-glucose [([.sup.18]F]FDG) positron emission...
Measurement | Pets | Fluoride treatment | PET imaging | Breast cancer | Diagnosis | Metastasis | Glucose | Comparative analysis | Dextrose
Measurement | Pets | Fluoride treatment | PET imaging | Breast cancer | Diagnosis | Metastasis | Glucose | Comparative analysis | Dextrose
Journal Article
Health and quality of life outcomes, ISSN 1477-7525, 11/2018, Volume 16, Issue 1, pp. 216 - 12
Adherence to long-term chelation therapy in transfusion-dependent patients is critical to prevent iron overload-related complications. Once-daily deferasirox...
Deferasirox | Iron overload | Iron chelation | Patient-reported outcomes | THALASSEMIA PATIENTS | OVERLOAD | EFFICACY | IRON CHELATION-THERAPY | DEFEROXAMINE | PEDIATRIC-PATIENTS | HEALTH CARE SCIENCES & SERVICES | ICL670 | HEALTH POLICY & SERVICES | QUALITY-OF-LIFE | EXJADE(R) | PALATABILITY | Iron Chelating Agents - therapeutic use | Iron Overload - prevention & control | Humans | Middle Aged | Deferoxamine - therapeutic use | Male | Thalassemia - psychology | Patient Satisfaction | Blood Transfusion | Myelodysplastic Syndromes - psychology | Quality of Life | Adult | Female | Thalassemia - drug therapy | Chelation Therapy - methods | Myelodysplastic Syndromes - drug therapy | Patient Reported Outcome Measures | Care and treatment | Anemia | Complications | Analysis | Patient outcomes | Surgery | Patient satisfaction | Risk factors | Drugs | Therapy | Transfusion | Compliance | Tablets | Iron | Swallowing | Myelodysplastic syndrome | Randomization | Chelation | Chronic illnesses | Formulations | Urine | Thalassemia | Chelation therapy | Patients | Adhesion | Quality of life | Studies | Medicine | Side effects | Palatability | Pharmacoeconomics | Taste
Deferasirox | Iron overload | Iron chelation | Patient-reported outcomes | THALASSEMIA PATIENTS | OVERLOAD | EFFICACY | IRON CHELATION-THERAPY | DEFEROXAMINE | PEDIATRIC-PATIENTS | HEALTH CARE SCIENCES & SERVICES | ICL670 | HEALTH POLICY & SERVICES | QUALITY-OF-LIFE | EXJADE(R) | PALATABILITY | Iron Chelating Agents - therapeutic use | Iron Overload - prevention & control | Humans | Middle Aged | Deferoxamine - therapeutic use | Male | Thalassemia - psychology | Patient Satisfaction | Blood Transfusion | Myelodysplastic Syndromes - psychology | Quality of Life | Adult | Female | Thalassemia - drug therapy | Chelation Therapy - methods | Myelodysplastic Syndromes - drug therapy | Patient Reported Outcome Measures | Care and treatment | Anemia | Complications | Analysis | Patient outcomes | Surgery | Patient satisfaction | Risk factors | Drugs | Therapy | Transfusion | Compliance | Tablets | Iron | Swallowing | Myelodysplastic syndrome | Randomization | Chelation | Chronic illnesses | Formulations | Urine | Thalassemia | Chelation therapy | Patients | Adhesion | Quality of life | Studies | Medicine | Side effects | Palatability | Pharmacoeconomics | Taste
Journal Article
Colorectal Disease, ISSN 1462-8910, 07/2017, Volume 19, Issue S1, pp. 37 - 66
SURGERY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ENETS CONSENSUS GUIDELINES | RANDOMIZED CLINICAL-TRIAL | EXTRALEVATOR ABDOMINOPERINEAL EXCISION | QUALITY-OF-LIFE | LAPAROSCOPIC-ASSISTED RESECTION | HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY | SURGERY ENHANCED-RECOVERY | GASTROENTEROLOGY & HEPATOLOGY | COMPLETE MESOCOLIC EXCISION | TOTAL MESORECTAL EXCISION | Patient Care Team - standards | Chemoradiotherapy, Adjuvant - standards | Terminal Care - standards | Humans | Chemotherapy, Adjuvant - standards | Chemoradiotherapy, Adjuvant - adverse effects | Antineoplastic Agents - therapeutic use | Lymphatic Metastasis | Rectal Neoplasms - therapy | Interdisciplinary Communication | Digestive System Surgical Procedures | Radiotherapy, Adjuvant - methods | Palliative Care - standards | Radiotherapy, Adjuvant - standards | Rectal Neoplasms - pathology | Neoadjuvant Therapy - standards | Colon cancer | Colon | Anus | Rectum | Cancer
Journal Article
PLoS ONE, 06/2014, Volume 9, Issue 6
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 10/2017, Volume 44, Issue 11, p. 1845
Purpose Measurement of heterogeneity in 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) images is reported to improve tumour phenotyping...
Transformation | Positron emission | Benign | Nervous system | Order parameters | Entropy | Heterogeneity | Neurofibromatosis | Phenotyping | Emission measurements | Tomography | Differentiation | Positron emission tomography | Tumors | Cancer
Transformation | Positron emission | Benign | Nervous system | Order parameters | Entropy | Heterogeneity | Neurofibromatosis | Phenotyping | Emission measurements | Tomography | Differentiation | Positron emission tomography | Tumors | Cancer
Journal Article
2010, Radiotherapy in practice, ISBN 0191575232
"This book has been written to guide both oncologists and radiologists in the use of imaging in the management of patients with malignancy. The site specific...
Radiotherapy Dosage | radiothérapie | Dosimétrie en radiothérapie | Diagnostic par imagerie | Radiotherapy | Neoplasms | Medicine | Diagnostic Imaging | tumeurs | Diagnosis | diagnostic | Neoplasm Staging | Stade de la tumeur | Cancer | Tumors
Radiotherapy Dosage | radiothérapie | Dosimétrie en radiothérapie | Diagnostic par imagerie | Radiotherapy | Neoplasms | Medicine | Diagnostic Imaging | tumeurs | Diagnosis | diagnostic | Neoplasm Staging | Stade de la tumeur | Cancer | Tumors
Web Resource
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 3, pp. 715 - 721
Purpose To describe the MRI appearances of squamous cell carcinoma of the anal canal before and after chemoradiation and to assess whether MRI features predict...
Radiology | Hematology, Oncology and Palliative Medicine | MRI | Chemoradiation | Anal cancer | Imaging | Prognostic features | EPIDERMOID CARCINOMA | RANDOMIZED-TRIAL | MITOMYCIN | PATTERNS | FLUOROURACIL | CANCER | CHEMOTHERAPY | RADIATION-THERAPY | ONCOLOGY | RECURRENCE | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Treatment Outcome | Anus Neoplasms - pathology | Tumor Burden | Carcinoma, Squamous Cell - radiotherapy | Neoplasm Recurrence, Local - pathology | Magnetic Resonance Imaging | Carcinoma, Squamous Cell - drug therapy | Analysis of Variance | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Carcinoma, Squamous Cell - secondary | Female | Retrospective Studies | Neoplasm Staging | Anal Canal - pathology | Squamous cell carcinoma | Care and treatment | Prognosis | Magnetic resonance imaging | Patient outcomes | Chronic diseases | Cancer | Age | LARGE INTESTINE | GASTROINTESTINAL TRACT | DIAGNOSTIC TECHNIQUES | NEOPLASMS | DIGESTIVE SYSTEM | INTESTINES | MEDICINE | ORGANS | NMR IMAGING | DISEASES | THERAPY | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | BODY | COMBINED THERAPY
Radiology | Hematology, Oncology and Palliative Medicine | MRI | Chemoradiation | Anal cancer | Imaging | Prognostic features | EPIDERMOID CARCINOMA | RANDOMIZED-TRIAL | MITOMYCIN | PATTERNS | FLUOROURACIL | CANCER | CHEMOTHERAPY | RADIATION-THERAPY | ONCOLOGY | RECURRENCE | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Treatment Outcome | Anus Neoplasms - pathology | Tumor Burden | Carcinoma, Squamous Cell - radiotherapy | Neoplasm Recurrence, Local - pathology | Magnetic Resonance Imaging | Carcinoma, Squamous Cell - drug therapy | Analysis of Variance | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Carcinoma, Squamous Cell - secondary | Female | Retrospective Studies | Neoplasm Staging | Anal Canal - pathology | Squamous cell carcinoma | Care and treatment | Prognosis | Magnetic resonance imaging | Patient outcomes | Chronic diseases | Cancer | Age | LARGE INTESTINE | GASTROINTESTINAL TRACT | DIAGNOSTIC TECHNIQUES | NEOPLASMS | DIGESTIVE SYSTEM | INTESTINES | MEDICINE | ORGANS | NMR IMAGING | DISEASES | THERAPY | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | BODY | COMBINED THERAPY
Journal Article
Investigative Radiology, ISSN 0020-9996, 01/2012, Volume 47, Issue 1, pp. 2 - 4
With the emergence of novel targeted therapies, imaging techniques that assess tumor vascular support have gained credence for response assessment alongside...
Perfusion CT | Novel therapies | Response assessment | Cancer | CT PERFUSION | BEVACIZUMAB | SIZE | TUMOR RESPONSE | MONOCLONAL-ANTIBODY | BLOOD-FLOW | perfusion CT | RENAL-CELL CARCINOMA | CHEMOTHERAPY | LUNG-CANCER | ATTENUATION | response assessment | cancer | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | novel therapies | Neoplasms - complications | Neoplasms - therapy | Perfusion Imaging - trends | Biomarkers, Tumor - analysis | Humans | Tomography, X-Ray Computed - trends | Treatment Outcome | Outcome Assessment (Health Care) - trends | Neoplasms - diagnostic imaging | Neovascularization, Pathologic - complications | Neovascularization, Pathologic - diagnostic imaging | Neovascularization, Pathologic - therapy
Perfusion CT | Novel therapies | Response assessment | Cancer | CT PERFUSION | BEVACIZUMAB | SIZE | TUMOR RESPONSE | MONOCLONAL-ANTIBODY | BLOOD-FLOW | perfusion CT | RENAL-CELL CARCINOMA | CHEMOTHERAPY | LUNG-CANCER | ATTENUATION | response assessment | cancer | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | novel therapies | Neoplasms - complications | Neoplasms - therapy | Perfusion Imaging - trends | Biomarkers, Tumor - analysis | Humans | Tomography, X-Ray Computed - trends | Treatment Outcome | Outcome Assessment (Health Care) - trends | Neoplasms - diagnostic imaging | Neovascularization, Pathologic - complications | Neovascularization, Pathologic - diagnostic imaging | Neovascularization, Pathologic - therapy
Journal Article